Soldier cases (N = 50) | Soldier healthy controls (N = 50) | P value | |
---|---|---|---|
Age, median (IQR), years | 26.5 (23, 31) | 25 (23, 33) | 0.82 |
Height, cm | 178 (175, 183)a | 177 (173, 185) | 0.95 |
Weight, kg | 87 (78, 99)a | 86 (75, 98) | 0.83 |
Body surface area, kg/m2 | 2.1 (2.0, 2.2)b | 2.1 (1.9, 2.2) | 0.80 |
Gender, male | 49 (98%) | 49 (98%) | 0.75 |
Active duty | 49 (98%) | 49 (98%) | 1.00 |
Creatinine, mg/dL | 0.9 (0.9, 1.0)c | 1.1 (1.0, 1.2)c | n/a |
Hematocrit, % | 44 (43, 46)a | 42 (41, 44)d | n/a |
Acute cardiovascular symptoms, N, % | 42 (86%) | n/a | n/a |
(*Convalescent) CV symptoms | 46 (94%) | n/a | |
Dyspnea on exertion | 41 (84%) | 3 (6%) | < 0.001 |
Chest pain | 35 (71%) | 21 (42%) | 0.005 |
Palpitations | 9 (18%) | 6 (12%) | 0.401 |
COVID-19 severity N (%) | |||
Mild (no CV symptoms) | 2 (4%) | n/a | n/a |
Moderate (CV symptoms) | 42 (86%) | n/a | |
Severe (hospitalized) | 3 (6%) | ||
Severe (ICU) | 2 (4%) | ||
CV PASC | |||
Survey completion, N, % | 19 (39%) | n/a | n/a |
Median time to survey (days) | 91 | ||
Ongoing CV symptoms | 6 (32%) | ||
Laboratory | |||
Troponin I > 99% | 2 (4%)a | 0 (0%)e | n/a |
Abnormal ECG | 4 (8.5%)a | 9 (28%)f | 0.05 |
Hematocrit | 44 (43, 45)c | 42 (41, 43)d | 0.06 |